Nucleon inc. had a competitive advantage over the competitors in pharmaceutical development technologies. Availability and exploitation of resources are based on high improved and advanced molecular biology and immunology. The competitors’ firms in the microbiology research in pharmaceutical enterprises were Elililly, Merck and Hoffman-LaRoche.
Presentations of values of Nucleon Inc. are on extensively doing research on CRP-1 molecule through studying genetic sequence. It has provided opportunities for the firm to become most competitive in pharmaceutical. The concern is on the development of technologies used in achieving the original results that helps in gaining patent right. The successes in research ...
